Charles Schwab Investment Management Inc Applied Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 700,836 shares of APLT stock, worth $364,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700,836
Previous 735,217
4.68%
Holding current value
$364,434
Previous $6.25 Million
90.48%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$5.98 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$5.2 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$5 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.58 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.56 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $25M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...